PULSION Medical Systems SE
PULSION Medical Systems SE engages in the development, production, and distribution of monitoring, diagnostic, and therapy control systems for recording physiological parameters of hospitalized, seriously ill, and intensive care patients. Its technologies include the PiCCO2 platform, a system used in intensive care medicine for the treatment of critically ill patients; PulsioFlex, which offers te… Read more
PULSION Medical Systems SE (PUS) - Total Assets
Latest total assets as of December 2017: €35.15 Million EUR
Based on the latest financial reports, PULSION Medical Systems SE (PUS) holds total assets worth €35.15 Million EUR as of December 2017.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
PULSION Medical Systems SE - Total Assets Trend (2000–2024)
This chart illustrates how PULSION Medical Systems SE’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
PULSION Medical Systems SE - Asset Composition Analysis
Current Asset Composition (December 2024)
PULSION Medical Systems SE's total assets of €35.15 Million consist of 66.9% current assets and 33.1% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0.0% |
| Accounts Receivable | €324.93K | 0.8% |
| Inventory | €4.61 Million | 11.6% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €12.35 Million | 30.9% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2000–2024)
This chart illustrates how PULSION Medical Systems SE's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: PULSION Medical Systems SE's current assets represent 66.9% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, down from 26.0% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 30.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is intangible assets at 30.9% of total assets.
PULSION Medical Systems SE Competitors by Total Assets
Key competitors of PULSION Medical Systems SE based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cheelcare Inc.
V:CHER
|
Canada | CA$4.27 Million |
|
FluroTech Ltd
OTCQB:FLURF
|
USA | $282.20K |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩119.28 Billion |
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
PULSION Medical Systems SE - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - PULSION Medical Systems SE generates 1.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, PULSION Medical Systems SE generates $ 1.36 in net profit.
PULSION Medical Systems SE - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.28 | 1.89 | 1.89 |
| Quick Ratio | 2.12 | 1.05 | 1.05 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €12.13 Million | € 7.44 Million | € 7.44 Million |
PULSION Medical Systems SE - Advanced Valuation Insights
This section examines the relationship between PULSION Medical Systems SE's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 8.42 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 18.9% |
| Total Assets | €39.93 Million |
| Market Capitalization | $206.38K USD |
Valuation Analysis
Below Book Valuation: The market values PULSION Medical Systems SE's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: PULSION Medical Systems SE's assets grew by 18.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for PULSION Medical Systems SE (2000–2024)
The table below shows the annual total assets of PULSION Medical Systems SE from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €39.93 Million | +18.85% |
| 2023-12-31 | €33.59 Million | -0.97% |
| 2022-12-31 | €33.92 Million | +8.08% |
| 2021-12-31 | €31.39 Million | -7.82% |
| 2020-12-31 | €34.05 Million | +10.49% |
| 2019-12-31 | €30.82 Million | -11.10% |
| 2018-12-31 | €34.66 Million | -1.37% |
| 2017-12-31 | €35.14 Million | +0.21% |
| 2016-12-31 | €35.07 Million | -46.80% |
| 2015-12-31 | €65.92 Million | +151.98% |
| 2013-12-31 | €26.16 Million | -18.76% |
| 2012-12-31 | €32.20 Million | +8.37% |
| 2011-12-31 | €29.71 Million | +15.47% |
| 2010-12-31 | €25.73 Million | -0.05% |
| 2009-12-31 | €25.75 Million | +7.96% |
| 2008-12-31 | €23.85 Million | -11.12% |
| 2007-12-31 | €26.83 Million | +18.04% |
| 2006-12-31 | €22.73 Million | +14.93% |
| 2005-12-31 | €19.78 Million | +13.22% |
| 2004-12-31 | €17.47 Million | +5.92% |
| 2003-12-31 | €16.49 Million | -15.29% |
| 2002-12-31 | €19.47 Million | -6.35% |
| 2001-12-31 | €20.79 Million | +73.74% |
| 2000-12-31 | €11.97 Million | -- |